title: Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results.
authors.forename: C
authors.initials: C
authors.lastname: Gottlieb
authors.forename: D J
authors.initials: DJ
authors.lastname: Callans
authors.forename: F
authors.initials: F
authors.lastname: Marchlinski
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000628:therapy; D002303:Cardiac Output, Low / Q000188:drug therapy / Q000628:therapy; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D015996:Survival Rate; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000628:therapy; D014481:United States; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000628:therapy; D016277:Ventricular Function, Left
chemical_list: D000889:Anti-Arrhythmia Agents